By Christopher P. Cannon (Editor), Patrick T. O'Gara (Editor)
Read Online or Download Critical Pathways in Cardiology PDF
Similar cardiology books
Completely revised and up-to-date, the second one variation of this pocket-sized guide offers accomplished, concise, evidence-based info on diagnosing and treating cardiac issues. The Little Black ebook of Cardiology is a handy source providing easy accessibility to very important info and makes an outstanding reference for fixing urgent difficulties at the ward or within the health facility.
The e-book will offer a close evidence-based method of key matters within the pathophysiology, prognosis, and administration of sufferers with concurrent clinical concerns. it is going to offer a scientific concentration with functional suggestion at the prevention, prognosis, and remedy of center illness supported by means of an expert’s precis, with out duplicating different texts.
Dieses Buch gibt einen hervorragenden Überblick über den Stand der wissenschaftlichen Forschungen auf dem Gebiet der Pharmakologie der Calcium-Antagonisten. Die Pharmakokinetik der verschiedenen Calcium-Antagonisten wird ebenso beschrieben, wie die Anwendung in der Praxis bei den verschiedensten Erkrankungen des Herz-Kreislauf-Systems.
The speed of healing advances within the therapy of cardiovascular illnesses is swift, and new clinically-relevant details seems with such frequency that it may be super demanding for clinicians to maintain. nonetheless, wisdom and interpretation of significant medical trials is essential for the variety of clinicians who deal with cardiovascular sufferers, specially on account that vital trial proof frequently has to be applied quickly after it truly is released.
Extra resources for Critical Pathways in Cardiology
The findings from TIMI-IIB, with the added support of the findings from the Should We Intervene Following Thrombolysis? (SWIFT) trial, and other studies, lend strong support to the notion that coronary angiography can be reserved for patients who demonstrate recurrent ischemia after thrombolysis for ST-segment elevation MI (46,47,48,49,50,51 and 52,56). In the current era of cost containment, close scrutiny of the indications for cardiac catheterization, with more strict adherence to its need in patients with documented recurrent ischemia after MI, may allow reductions in the use of cardiac procedures (and thus costs), without any loss of clinical benefit.
Association of thrombolysis medication errors with increased mortality in the Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries (GUSTO)-I trial. (Data from Vorchheimer DA, Baruch L, Thompson TD, et al. North American vs. non–North American streptokinase use in GUSTO-I: impact of protocol deviation on mortality benefit of tPA. Circulation 1997;96[Suppl I]:I-535; reproduced from Cannon CP. Thrombolysis medication errors: benefits of bolus thrombolytic agents. 7% vs. 001).
N Engl J Med 1996;335:1333–1341. 46. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342–1349. 47. Polanczyk CA, Lee TH, Cook EFD, et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol 1998;32:8–14. 48. Antman EM, Sacks DB, Rifai N, et al. Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a thrombolysis in myocardial infarction (TIMI) 11A Substudy.
Critical Pathways in Cardiology by Christopher P. Cannon (Editor), Patrick T. O'Gara (Editor)